phosphorylethanolamine has been researched along with dihydroceramide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| AlAnezi, AZ; Clark, RB; Jiang, J; Jiang, X; Nichols, FC; Rowe, DW; Wang, YH; Zhu, Q | 1 |
| Davey, ME; Ho, A; Mao, C; Movila, A; Nichols, F; Nusbaum, A; Xu, R; Yamada, C | 1 |
2 other study(ies) available for phosphorylethanolamine and dihydroceramide
| Article | Year |
|---|---|
Porphyromonas gingivalis lipids inhibit osteoblastic differentiation and function.
Topics: Alveolar Bone Loss; Animals; Apoptosis; Cell Differentiation; Cell Proliferation; Cells, Cultured; Ceramides; Ethanolamines; Gene Expression; Lipids; Mice; Osteoblasts; Porphyromonas gingivalis; Toll-Like Receptor 2 | 2010 |
Inhibitory effect of Porphyromonas gingivalis-derived phosphoethanolamine dihydroceramide on acid ceramidase expression in oral squamous cells.
Topics: Acid Ceramidase; Carcinoma, Squamous Cell; Ceramides; Epithelial Cells; Head and Neck Neoplasms; Humans; Mouth Neoplasms; Porphyromonas gingivalis; Prospective Studies; Squamous Cell Carcinoma of Head and Neck | 2023 |